Retinoid-suppressed phosphorylation of RARα mediates the differentiation pathway of osteosarcoma cells

[1]  T. Triche,et al.  Loss of CAK phosphorylation of RARa mediates transcriptional control of retinoid‐induced cancer cell differentiation , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  A. Wagers,et al.  Osteolineage niche cells initiate hematopoietic stem cell mobilization. , 2008, Blood.

[3]  Cun-Yu Wang,et al.  Wnt signaling and skeletal development. , 2008, Cellular signalling.

[4]  P. Choong,et al.  A review of clinical and molecular prognostic factors in osteosarcoma , 2008, Journal of Cancer Research and Clinical Oncology.

[5]  T. Triche,et al.  Intrinsic Retinoic Acid Receptor α‐Cyclin‐Dependent Kinase‐Activating Kinase Signaling Involves Coordination of the Restricted Proliferation and Granulocytic Differentiation of Human Hematopoietic Stem Cells , 2007, Stem cells.

[6]  P. Härkönen,et al.  Role of fibroblast growth factor 8 in growth and progression of hormonal cancer. , 2007, Cytokine & growth factor reviews.

[7]  Linheng Li,et al.  Understanding hematopoietic stem-cell microenvironments. , 2006, Trends in biochemical sciences.

[8]  T. Triche,et al.  Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin‐dependent kinase‐activating kinase binding and phosphorylation of PML/RAR , 2006 .

[9]  V. Nurcombe,et al.  Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. , 2006, Gene.

[10]  M. Katoh,et al.  Cross-talk of WNT and FGF signaling pathways at GSK3ß to regulate ß-catenin and SNAIL signaling cascades , 2006, Cancer biology & therapy.

[11]  David M. Thomas,et al.  Epigenetic modifications in osteogenic differentiation and transformation , 2006, Journal of cellular biochemistry.

[12]  D. Schatz,et al.  B cells and osteoblast and osteoclast development , 2005, Immunological reviews.

[13]  R. Fisher.  Secrets of a double agent: CDK7 in cell-cycle control and transcription , 2005, Journal of Cell Science.

[14]  T. Shimada,et al.  Regulation of the human tissue-nonspecific alkaline phosphatase gene expression by all-trans-retinoic acid in SaOS-2 osteosarcoma cell line. , 2005, Bone.

[15]  Xiang‐Dong Wang.  Alcohol, vitamin A, and cancer. , 2005, Alcohol.

[16]  Di Chen,et al.  Bone Morphogenetic Proteins , 2004, Growth factors.

[17]  T. Triche,et al.  Retinoid‐modulated MAT1 ubiquitination and CAK activity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  H. Melhus,et al.  Vitamin A differentially regulates RANKL and OPG expression in human osteoblasts. , 2004, Biochemical and biophysical research communications.

[19]  J. Bastien,et al.  Nuclear retinoid receptors and the transcription of retinoid-target genes. , 2004, Gene.

[20]  T. Underhill,et al.  Molecular Mechanisms Regulating Chondroblast Differentiation , 2003, The Journal of bone and joint surgery. American volume.

[21]  G. Xiao,et al.  Regulation of the osteoblast‐specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways , 2003, Journal of cellular biochemistry.

[22]  T. Triche,et al.  Retinoid-induced G1 Arrest and Differentiation Activation Are Associated with a Switch to Cyclin-dependent Kinase-activating Kinase Hypophosphorylation of Retinoic Acid Receptor α* , 2002, The Journal of Biological Chemistry.

[23]  D. Crowe,et al.  A phosphorylation defective retinoic acid receptor mutant mimics the effects of retinoic acid on EGFR mediated AP-1 expression and cancer cell proliferation , 2002, Cancer Cell International.

[24]  P. Marie,et al.  FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. , 2002, Genes & development.

[25]  T. Klimkait,et al.  Promoter of FGF8 reveals a unique regulation by unliganded RARalpha. , 2002, Journal of molecular biology.

[26]  Á. Pascual,et al.  Nuclear hormone receptors and gene expression. , 2001, Physiological reviews.

[27]  A. Skoultchi,et al.  Coordinating cell proliferation and differentiation. , 2001, Current opinion in genetics & development.

[28]  T. Triche,et al.  MAT1-Modulated CAK Activity Regulates Cell Cycle G1 Exit , 2001, Molecular and Cellular Biology.

[29]  P. Chambon,et al.  The AF-1 and AF-2 activating domains of retinoic acid receptor-alpha (RARalpha) and their phosphorylation are differentially involved in parietal endodermal differentiation of F9 cells and retinoid-induced expression of target genes. , 2000, Molecular endocrinology.

[30]  V. Brondani,et al.  Retinoic acid switches differential expression of FGF8 isoforms in LNCaP cells. , 2000, Biochemical and biophysical research communications.

[31]  T. Fujinaga,et al.  Influence of vitamin D and retinoids on the induction of functional differentiation in vitro of canine osteosarcoma clonal cells. , 2000, Veterinary journal.

[32]  M. Mochizuki,et al.  Differentiation induction of canine osteosarcoma cell lines by retinoids. , 2000, Research in veterinary science.

[33]  T. Fujinaga,et al.  Induction of functional differentiation and growth inhibition in vitro of canine osteosarcoma by 22-oxacalcitriol, calcitriol and all-trans retinoic acid. , 1999, Zentralblatt fur Veterinarmedizin. Reihe A.

[34]  Jonathan D. Licht,et al.  Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia , 1999 .

[35]  P. Chambon,et al.  Phosphorylation of activation functions AF‐1 and AF‐2 of RARα and RARγ is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment , 1997 .

[36]  P. Chambon,et al.  Stimulation of RARα Activation Function AF-1 through Binding to the General Transcription Factor TFIIH and Phosphorylation by CDK7 , 1997, Cell.

[37]  P. Chambon.  A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  J. Gemel,et al.  Structure and sequence of human FGF8. , 1996, Genomics.

[39]  E. Nigg.  Cyclin-dependent kinase 7: at the cross-roads of transcription, DNA repair and cell cycle control? , 1996, Current opinion in cell biology.

[40]  R. Taichman,et al.  Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. , 1996, Blood.

[41]  E. Nigg,et al.  In vitro assembly of a functional human CDK7‐cyclin H complex requires MAT1, a novel 36 kDa RING finger protein. , 1995, The EMBO journal.

[42]  S. Wientroub,et al.  Differential effects of retinoic acid and growth factors on osteoblastic markers and CD10/NEP activity in stromal‐derived osteoblasts , 1994, Journal of cellular biochemistry.

[43]  David O. Morgan,et al.  A novel cyclin associates with M015/CDK7 to form the CDK-activating kinase , 1994, Cell.

[44]  L. Wu,et al.  Molecular cloning of the human CAK1 gene encoding a cyclin-dependent kinase-activating kinase. , 1994, Oncogene.

[45]  R. Taichman,et al.  Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor , 1994, The Journal of experimental medicine.

[46]  T. Martin,et al.  Cell substratum modulates responses of preosteoblasts to retinoic acid , 1993, Journal of cellular physiology.

[47]  Hickman Ja,et al.  Differentiation: a suitable strategy for cancer chemotherapy? , 1993, Anti-cancer drug design.

[48]  R. Derynck,et al.  Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. , 1993, Molecular endocrinology.

[49]  J. Lehmann,et al.  Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid , 1992, Nature.

[50]  K. Umesono,et al.  A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR , 1991, Cell.

[51]  P. Chambon,et al.  Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid. , 1991, The EMBO journal.

[52]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[53]  T. Triche,et al.  Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RARalpha. , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  T. Triche,et al.  Advances in Brief MAT 1-Modulated Cyclin-Dependent Kinase-Activating Kinase Activity Cross-Regulates Neuroblastoma Cell G 1 Arrest and Neurite Outgrowth , 2004 .

[55]  S. Ferrari,et al.  Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. , 2001, European journal of cancer.

[56]  M. Mochizuki,et al.  In vitro retinoid-induced growth inhibition and morphologic differentiation of canine osteosarcoma cells. , 2000, American journal of veterinary research.

[57]  J. Licht,et al.  Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. , 1999, Blood.

[58]  G. P. Studzinski,et al.  Differentiation-related changes in the cell cycle traverse. , 1999, International review of cytology.

[59]  P. Chambon,et al.  Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. , 1997, The EMBO journal.

[60]  L. Song.  Effects of retinoic acid and dexamethasone on proliferation, differentiation, and glucocorticoid receptor expression in cultured human osteosarcoma cells. , 1994, Oncology research.